Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose

BACKGROUND/AIMS: Sofosbuvir (SOF)-based therapy has been used in Korean patients with chronic hepatitis C virus (HCV) infection since January 2016. This study aimed to investigate the real-life effectiveness and safety of SOF-based therapy in genotype 2 HCV infection. METHODS: From January to Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Eun Sun, Kim, Kyung-Ah, Kim, Young Seok, Kim, In Hee, Lee, Byung Seok, Lee, Youn Jae, Chung, Woo Jin, Jeong, Sook-Hyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667937/
https://www.ncbi.nlm.nih.gov/pubmed/32000468
http://dx.doi.org/10.5009/gnl19260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667937/
https://www.ncbi.nlm.nih.gov/pubmed/32000468
http://dx.doi.org/10.5009/gnl19260

Ejemplares similares